Bcl-2 anti-apoptotic oncoprotein suppresses angiogenesis in non-small cell lung cancer. Implications in resistance to photo-dynamic treatment ?

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 3423, Issue , 1998, Pages 432-435

  Koukourakis, M I ^a   Giatromanolaki, A ^a   Skarlatos, J ^a   Kosma, L ^a   Apostolikas, N ^a   Beroukas, K ^a  

^a Agios Savvas Cancer Hospital   (Greece)

Author keywords

Angiogenesis; Bcl 2; Non small cell lung cancer; PDT

Indexed keywords

BIOLOGICAL ORGANS; CELL DEATH; DISEASES; OXYGENATION; PATIENT MONITORING; PATIENT TREATMENT;

ANGIOGENESIS; ANTI-APOPTOTIC PROTEIN; BCL-2; DYNAMIC TREATMENTS; NON SMALL CELL LUNG CANCER; ONCOPROTEINS; OVER-EXPRESSION; OXIDATIVE PRODUCTS;

LASER APPLICATIONS;

EID: 0342491406     PISSN: 0277786X     EISSN: 1996756X     Source Type: Conference Proceeding    
DOI: 10.1117/12.316631     Document Type: Conference Paper

References (9)

1. Vaux D, Cory S, Adams J. Bcl-2 gene promotes haemopoietic cell survival and co-operates with c-myc to immortalize pre-B cells. Nature (Lond), 1988;335:440-442
2. Garcia I, Martinou I, Tsujimoto Y, Martinou JC. Prevention of programmed cell death of sympathetic neurones by the bcl-2 proto-oncogene. Science (Wash D. C) 1992;258:302-304
3. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 1990;43:752-757
4. Giatromanolaki A, Koukourakis M, O'Byrne K, Fox S, Whitehouse R, Talbot D, Harris AL, Gatter KC. Angiogenesis is a significant prognostic marker in operable non small cell lung cancer. J Pathol (in press), 1995.
5. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter K, Mason DY. bcl-2 protein in non small cell lung carcinoma. N Engl J Med 1993; 329:690-694
6. Koukourakis MI, Giatromanolaki A, O'Byrne K, Comley M, Whitehouse R, Talbot DC, Gatter KC, and Harris AL. Platelet-Derived Endothelial Cell Growth Factor expression correlates with tumor angiogenesis and prognosis in non-small cell lung cancer. Br J Cancer 1997;4:477-481
7. Kane DJ, Sarafin TA, Auton S, Hahn H, Gralla FB, Valentine JC, Ord T, Bredesen DE. Bcl-2 inhibition of neural cell death: decreased generation of reactive oxygen species. Science (Wash. D. C) 1993, 262:1274-1276
8. Hennet T, Bertoni G, Richter C, Peterhans E. Expression of bcl-2 protein enhences the survival of of mouse fibrosarcoid cells in tumor necrosis factor mediated cytotoxicity. Cancer Res 1993;53:1456-1460
9. Haldar S, Basu A, Croce CM. Bcl2 is the guardian of microtubule integrity. Cancer Res 1997, 57:229-233